Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
- PMID: 30402091
- PMCID: PMC6198559
- DOI: 10.1155/2018/6090878
Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
Abstract
Objective: Several recent reviews of published studies have shown that the eradication of H. pylori infection in patients with ITP improved thrombocytopenia in about half of the cases. However, most included studies were observational case series. We performed the first meta-analysis of randomized trials to gain a better insight into the effect of H. pylori eradication in ITP patients.
Methods: A systematic computerized search of the electronic databases including PubMed, EMBASE, Google Scholar, and Cochrane Library (up to December 2017) was conducted.
Results: From six studies, a total of 241 patients (125 in eradication group and 116 in control group) were included in the meta-analysis. Patients in the eradication group showed significantly higher overall platelet response rate than those in the control group (odds ratio = 1.93, 95% confidence interval: 1.01-3.71, P = 0.05). In the subgroup analysis, however, children in the eradication group failed to show statistically better response rate than those in the noneradication group (odds ratio = 1.80, 95% confidence interval: 0.88-3.65, P = 0.11).
Conclusions: This meta-analysis indicates that H. pylori eradication has a significant therapeutic effect in patients with ITP. Considering the intrinsic limits in the design and sample size of the included studies, however, large randomized controlled trials are warranted to validate the therapeutic impact of H. pylori eradication in adults as well as children with ITP.
Figures
Similar articles
-
Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis.J Antimicrob Chemother. 2007 Aug;60(2):237-46. doi: 10.1093/jac/dkm195. Epub 2007 Jun 7. J Antimicrob Chemother. 2007. PMID: 17561502 Review.
-
Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East.Blood Res. 2021 Mar 31;56(1):38-43. doi: 10.5045/br.2021.2020189. Blood Res. 2021. PMID: 33707351 Free PMC article.
-
Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.Int J Hematol. 2005 Feb;81(2):162-8. doi: 10.1532/ijh97.04146. Int J Hematol. 2005. PMID: 15765787
-
Helicobacter pylori infection and idiopathic thrombocytopenic purpura.Int J Hematol. 2005 Feb;81(2):113-8. doi: 10.1532/ijh97.04161. Int J Hematol. 2005. PMID: 15765778 Review.
-
Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.Int J Hematol. 2006 Nov;84(4):309-15. doi: 10.1532/IJH97.06188. Int J Hematol. 2006. PMID: 17118756 Review.
Cited by
-
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial.Trials. 2024 Jan 15;25(1):55. doi: 10.1186/s13063-024-07906-3. Trials. 2024. PMID: 38225650 Free PMC article.
-
Impact of Helicobacter pylori Infection upon the Evolution and Outcome of Pediatric Immune Thrombocytopenic Purpura: A Comprehensive Review.Diagnostics (Basel). 2023 Oct 13;13(20):3205. doi: 10.3390/diagnostics13203205. Diagnostics (Basel). 2023. PMID: 37892026 Free PMC article. Review.
-
Helicobacter pylori Infections in Children.Antibiotics (Basel). 2023 Sep 12;12(9):1440. doi: 10.3390/antibiotics12091440. Antibiotics (Basel). 2023. PMID: 37760736 Free PMC article. Review.
-
Successful treatment of coexisting membranous nephropathy and immune thrombocytopenia by eradicating gastric Helicobacter pylori infection: a case report.CEN Case Rep. 2023 Jul 8. doi: 10.1007/s13730-023-00805-7. Online ahead of print. CEN Case Rep. 2023. PMID: 37421572
-
Helicobacter pylori infection.Nat Rev Dis Primers. 2023 Apr 20;9(1):19. doi: 10.1038/s41572-023-00431-8. Nat Rev Dis Primers. 2023. PMID: 37081005 Review.
References
-
- George J. N., Woolf S. H., Raskob G. E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3–40. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
